Anesthesia, Echocardiography, Hypotension, Lung Ultrasound, Perioperative Complication
Conditions
Brief summary
Background: Intraoperative hypotension increases 30-day mortality and the risks of myocardial injury and acute renal failure. Patients with inadequate volume reserve before the induction of anesthesia are highly exposed. The identification of latent hypovolemia is therefore crucial. Ultrasonographic measurement of the inferior vena cava collapsibility index (IVCCI) is able to detect volume responsiveness in circulatory shock and growing evidence support the theory that higher IVCCI can predict intraoperative hypotension. The aim of the present study is to evaluate the potential benefit of an ultrasound-based protocol for preoperative fluid optimization. The investigators will perform a randomized-controlled study involving elective surgical patients. An ultrasound-based protocol (USP) arm and a conventional fluid therapy group (CFT) are to be formed. Ultrasound examinations will be performed twice in both groups: 2 hours and 30 minutes preoperatively. The inferior vena cava and the anterior lung fields will be scanned. In the USP group the participants will receive fluid therapy according to the ultrasonographic findings: high level of IVCCI and absence of signs of pulmonary edema will indicate fluid therapy. In the CFT group the attending anesthesiologist (blinded to the results of ultrasonography) will order fluid therapy on the basis of daily routine and clinical judgement. The investigators will evaluate the incidence of intraoperative hypotension (primary outcome), postoperative metabolic status and organ functions and the amount of the administered intravenous fluids in both groups.
Detailed description
A randomized-controlled study with 80 participants. The investigators will use computer-generated unpaired random allocation method to an ultrasound-based protocol (USP) group or to the conventional fluid therapy (CFT) group. Preoperative ultrasound examinations will be performed twice in both groups: 2 hours and 30 minutes preoperatively. The inferior vena cava and the lung fields (so called BLUE - Bedside Lung Ultrasound in Emergency - points: 2nd or 3rd intercostal space anterior, 5th-6th interspace anterior and posterior axillary line position) will be scanned. The collapsibility index (IVCCI) of the IVC is calculated, \>40 percent is considered 'high IVCCI'. Lung ultrasound (LUS) is evaluated as indicative for 'lung congestion' if symmetric anterior B-profiles (at least 3 B-lines in anterior lung fields) are detected. Baseline demographic (age, sex, height, weight) and comorbidity data (history of hypertension, chronic heart failure, coronary or cerebrovascular disease, respiratory illness e.g. COPD, past COVID, diabetes on insulin treatment) together with laboratory data (haemoglobin, creatinine, blood urea) are to be recorded. A standardized practice of monitoring and induction of general anesthesia will allow for the detection of immediate and early (first 10 minutes of anesthesia) hypotensive events. A follow up for 24 hours is necessary for evaluating the fulfillment of secondary endpoints. A semi-quantitative lung ultrasound after 24 hours will estimate lung aeration.
Interventions
PROCEDUREUltrasound-based protocol based fluid therapy
Protocol of the interventional group according to the ultrasonographic findings: Ultrasound scan 2 hours before surgery: IVCCI\>40 percent and absence of symmetric anterior 'B-profile' on the lung ultrasound indicate intravenous (IV) fluid therapy: 8 ml/kg of isotonic, balanced crystalloid infusion. IVCCI≤40 percent AND/OR symmetric anterior 'B-profile' contraindicates further IV fluid therapy. A 2nd ultrasound scan at 30 minutes before surgery: IVCCI\>40 percent and absence of symmetric anterior 'B-profile' on the lung ultrasound indicate further IV fluid therapy: 5 ml/kg of isotonic, balanced crystalloid infusion. IVCCI≤40 percent AND/OR symmetric anterior 'B-profile' contraindicates further IV fluid therapy.
Sponsors
Semmelweis University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Masking description
The attending anesthesiologist, participant and outcomes assessors will be blinded to randomization and result of preoperative ultrasound scans. The attending anesthesiologist (not aware of randomization and ultrasonographic findings) gives a dose recommendation for fluid therapy for all patients. The investigator will be aware of the randomization and ultrasound results. This investigator will choose the fluid therapy (conforming to the ultrasound based protocol OR to the dose-recommendation of the attending anesthesiologist) following the results of randomization and ultrasound scans in the USP group.
Intervention model description
Randomized, controlled study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Elective surgery * General surgical procedures * Estimated duration of anesthesia \> 60 minutes * ASA class 2 or 3
Exclusion criteria
* Emergency procedure * Reoperation, redo procedure * Patient who is incapable of acting * Uncontrolled hypotension (\<90 mmHg) * Uncontrolled hypertension (\>180 mmHg) * High risk valvular disease (Aortic Stenosis) * Endocrine hypertension (Conn's syndrome, phaeochromocytoma) * Sepsis (infection and SOFA≥2 pt) * Conditions blocking lung ultrasound (pneumothorax without drainage, former pulmonary resection, pleural effusion affecting more than 2 interspaces) * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of hypotension associated to general anesthesia induction | first 10 minutes of anesthesia | mean arterial pressure \< 65 mmHg AND/OR ≥30 percent of decrease compared to baseline (before induction of anesthesia) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Dose of preoperative fluid therapy (in millilitres) | preoperative time frame on the day of surgery | intravenous fluid therapy before anesthesia induction |
| Dose fluid therapy of the operative day (in millilitres) | 24 hours | all intravenous fluid therapy on the day of surgery |
| lung ultrasound score (LUS) | 24th postoperative hour | Summarized lung ultrasound score of 12 fields of the thorax (0-36 pts) |
| base excess (mmol/l) | 1st postoperative hour | worst base excess level in mmol of an arterial blood sample |
| urine output (millilitres/24 h) | 24 hours | summarized urine output after surgery |
| lactate level (mmol/l) | 1st postoperative hour | highest lactate level in mmol of an arterial blood sample |
Countries
Hungary
Outcome results
None listed